| Hans-Günter Meyer-Thompson | Methadon in der Krebsmedizin
Dubious effects of methadone as an "anticancer" drug on ovarian cancer cell-lines and patient-derived tumor-spheroids.
Dubious effects of methadone as an "anticancer" drug on ovarian cancer cell-lines and patient-derived tumor-spheroids.
Fiegl H, Hagenbuchner J, Kyvelidou C, Seeber B, Sopper S, Tsibulak I, Wieser V, Reiser E, Roessler J, Huhtinen K, Carpén O, Parson W, Sprung S, Marth C, Ausserlechner MJ, Zeimet AG.
Gynecol Oncol. 2022 Jan 12:S0090-8258(22)00009-9. doi: 10.1016/j.ygyno.2022.01.008. Epub ahead of print. PMID: 35033381.
https://www.gynecologiconcology-online.net/article/S0090-8258(22)00009-9/fulltext